Ionis Pharmaceuticals 10K 2012 Annual report | IONS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman V good

New words: AB, abdomen, Academy, AF, agricultural, alanine, alleviated, aminotransferase, angioedema, arthroplasty, aspartate, assist, assistance, AstraZeneca, attenuating, attorney, BESP, blunt, bore, Boxed, calendar, categorized, cGMP, channel, CHMP, citing, closest, compelling, competitor, constant, CornerstoneSM, Cushing, custirsen, customer, deducting, deliverable, detrimental, digit, DMPK, dozen, dystrophia, Eighteen, elizabeth, endotoxin, enoxaparin, epigenetic, EU, expert, explained, false, flat, frequency, FTB, glycemic, GMP, gradually, HAE, hematologic, hereditary, home, hougen, hypertension, hypothetical, ill, implicated, individually, ineffective, inflow, interdependent, interrelated, intraperiod, IPO, iron, IX, Juxtapid, Lancet, larynx, levofloxacin, literature, lost, margin, midyear, misleading, Monsanto, myotonic, objective, painful, Parhofer, patrick, PKK, pledge, pooled, prejudice, prekallikren, pressure, pretreatment, Professor, prophylactic, Raul, recapture, red, reexamination, release, relief, resell, RSU, Sarepta, simvastatin, skeletal, sought, subheading, swelling, SYNERGY, Taxpayer, ticker, titrated, TKA, Today, trachea, unchanged, underestimated, unspecified, unusually, uptake, Valeant, vendor, violated, violation, Warning, withdrawn, withdrew, Witwatersrand, wrote

Removed: accompanied, adding, AG, Altair, Alternately, annualized, attribute, AVI, BioPharma, Biotech, budget, CAD, calculation, carcinogenicity, closed, closer, CMV, comprise, consolidate, delivering, dismutase, dramatic, enabled, enterprise, Ercole, explanation, fomivirsen, governed, HCV, highlight, IDT, implemented, inflection, initiating, institutional, Integrated, inventive, issuable, john, launched, leased, leukemia, locally, mediated, methodology, myeloid, nominal, noncontrolling, Occasionally, ocular, OMJP, opportunistic, opposition, passed, persistent, prolific, proof, protease, putting, recoverable, reed, remeasure, repay, repurchased, resale, resolution, routinely, secondary, Similarly, solidified, spending, sudden, superoxide, supplier, surrogate, tertiary, tiered, Topic, Trust, understand, utility, vary, Vitravene

Ionis Pharmaceuticals (IONS) 10-K2012 FY Annual report

Content analysis